ZA200001501B - Benzo[3,4]cyclobuta[1,2-c]pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them. - Google Patents

Benzo[3,4]cyclobuta[1,2-c]pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them.

Info

Publication number
ZA200001501B
ZA200001501B ZA200001501A ZA200001501A ZA200001501B ZA 200001501 B ZA200001501 B ZA 200001501B ZA 200001501 A ZA200001501 A ZA 200001501A ZA 200001501 A ZA200001501 A ZA 200001501A ZA 200001501 B ZA200001501 B ZA 200001501B
Authority
ZA
South Africa
Prior art keywords
alkyl
aryl
cycloalkyl
cyclobuta
benzo
Prior art date
Application number
ZA200001501A
Other languages
English (en)
Inventor
Jean-Louis Pelion
Bertrand Goument
Aimee Dessinges
Mark Millan
Jean-Michael Rivet
Anne Dekeyne
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA200001501B publication Critical patent/ZA200001501B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
ZA200001501A 1999-03-26 2000-03-24 Benzo[3,4]cyclobuta[1,2-c]pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them. ZA200001501B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9903811A FR2791345B1 (fr) 1999-03-26 1999-03-26 Nouveaux derives du benzo[3,4]cyclobuta[1,2-c]pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ZA200001501B true ZA200001501B (en) 2000-10-24

Family

ID=9543685

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200001501A ZA200001501B (en) 1999-03-26 2000-03-24 Benzo[3,4]cyclobuta[1,2-c]pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them.

Country Status (22)

Country Link
US (1) US6153640A (hu)
EP (1) EP1038873B1 (hu)
JP (1) JP3256788B2 (hu)
KR (1) KR100427127B1 (hu)
CN (1) CN1166638C (hu)
AT (1) ATE216994T1 (hu)
AU (1) AU762990B2 (hu)
BR (1) BR0001420A (hu)
CA (1) CA2301787C (hu)
DE (1) DE60000142T2 (hu)
DK (1) DK1038873T3 (hu)
EA (1) EA003302B1 (hu)
ES (1) ES2176156T3 (hu)
FR (1) FR2791345B1 (hu)
HK (1) HK1031380A1 (hu)
HU (1) HUP0001246A3 (hu)
NO (1) NO315513B1 (hu)
NZ (1) NZ503588A (hu)
PL (1) PL339203A1 (hu)
PT (1) PT1038873E (hu)
SI (1) SI1038873T1 (hu)
ZA (1) ZA200001501B (hu)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4171369A (en) * 1972-09-29 1979-10-16 Sandoz Ltd. Hydro-4-phenyl-benz[f]isoindoline compounds
FI57748C (fi) * 1972-09-29 1980-10-10 Sandoz Ag Analogifoerfarande foer framstaellning av nya antidepressiva bens(f)isoindoliner
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
US4622405A (en) * 1984-07-25 1986-11-11 Abbott Laboratories 1,2,3,3a,8,8a-hexahydro-indeno[1,2-c]pyrroles useful in the treatment of hypertension
DE3576334D1 (de) * 1984-07-25 1990-04-12 Abbott Lab 1,2,3,3a,8,8a-hexahydro-indeno-(1,2-c)pyrrde.
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
US5049564A (en) * 1989-11-17 1991-09-17 Abbott Laboratories 5-HT selective agents
GB9012469D0 (en) * 1990-06-05 1990-07-25 Glaxo Group Ltd Medicaments
US5574060A (en) * 1993-08-12 1996-11-12 The United States Of America As Represented By The Department Of Health And Human Services Selective inhibitors of biogenic amine transporters
DE4341402A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
AU2257900A (en) 2000-09-28
BR0001420A (pt) 2000-10-10
EP1038873B1 (fr) 2002-05-02
HU0001246D0 (en) 2000-06-28
HUP0001246A2 (hu) 2001-01-29
CA2301787C (fr) 2004-11-02
PT1038873E (pt) 2002-09-30
HK1031380A1 (en) 2001-06-15
EA003302B1 (ru) 2003-04-24
EP1038873A3 (fr) 2000-10-04
NO315513B1 (no) 2003-09-15
HUP0001246A3 (en) 2002-02-28
EA200000260A2 (ru) 2000-12-25
FR2791345B1 (fr) 2001-05-04
FR2791345A1 (fr) 2000-09-29
DE60000142T2 (de) 2002-12-12
NZ503588A (en) 2000-12-22
NO20001542D0 (no) 2000-03-24
ES2176156T3 (es) 2002-12-01
AU762990B2 (en) 2003-07-10
SI1038873T1 (en) 2002-08-31
KR100427127B1 (ko) 2004-04-17
NO20001542L (no) 2000-09-27
JP2000290253A (ja) 2000-10-17
EP1038873A2 (fr) 2000-09-27
CN1274718A (zh) 2000-11-29
KR20010006863A (ko) 2001-01-26
CN1166638C (zh) 2004-09-15
DK1038873T3 (da) 2002-08-19
DE60000142D1 (de) 2002-06-06
US6153640A (en) 2000-11-28
PL339203A1 (en) 2000-10-09
JP3256788B2 (ja) 2002-02-12
ATE216994T1 (de) 2002-05-15
CA2301787A1 (fr) 2000-09-26

Similar Documents

Publication Publication Date Title
ZA908884B (en) 1,2-benzisoxazole derivatives processes for preparing them and pharmaceutical compositions containing them
AR037907A1 (es) Derivados de azaindolilalquilamina como ligandos de 5-hidroxitriptamina-6
NO20004295L (no) Nye pyridinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
BR9812239A (pt) Composto, formulação farmacêutica, uso do composto, processos para o tratamento de distúrbios, para o tratamento de distúrbios mediados por 5-hidroxitriptamina, e, para a preparação do composto
ZA200001501B (en) Benzo[3,4]cyclobuta[1,2-c]pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them.
ATE234305T1 (de) Dihydrofuro-(3,4-b)-chinolein-1-on derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
MX9306394A (es) Derivados de benzofurano, proceso para su preparacion y composicion farmaceutica que los contiene
SE9002727D0 (sv) Novel cyclic ketone derivatives and pharmaceuticalcompositions containing same as well as a process for their preparation
NO903512L (no) Nye 1-oxa-2-oxo-8-azaspiro(4,5)decanderivater, farmasoeytiske preparater som inneholder dem og fremgangsmaate for fremstilling av dem.
NO964672L (no) Nye tetracykliske 1,4-oksazinforbindelser, fremgangsmåter ved deres fremstilling og farmasöytiske sammensetninger innholdende dem
MX173856B (es) Procedimiento de preparacion de derivados de 1-aril-sulfonil-1,5-dihidro-2h-pirrol-2-ona y producto obtenido
SE8701524L (sv) Nya sulfonamider och deras framstaellningsfoerfarande
SE8802162L (sv) Nya aminoacylater av glycerolacetal
NO976101L (no) Nye ellipticinforbindelser, en fremgangsmÕte ved deres fremstilling, samt farmas°ytiske blandinger som inneholder dem